Phase 2 Aged Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Elderly (People Aged 65 or More)Sever Aplastic AnaemiaImmunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China65 enrolled1 locationNCT07010237
Completed
Phase 2
A Multicentre trial for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed Acute Lymphoblastic Leukaemia (ALL)
Untreated ALL aged 15 to 40 years
Australasian Leukaemia and Lymphoma Group100 enrolled15 locationsACTRN12611000814976
Completed
Phase 2Phase 3
The acceptability, safety and tolerability of combined methadone-naloxone in methadone maintained individuals aged between 18 - 65
Participants are opiod dependant and methadone maintained individuals aged between 18-65
Langton Centre10 enrolled1 locationACTRN12608000024347